Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter E Haefeli

Showing results (11-20 of 351) with videos related to

Pageof 36
Sort By:
Pharmacoepidemiology and Drug Safety|September 16, 2017
Refining estimates of prescription durations by using observed covariates in pharmacoepidemiologic databases: Necessary refinements to stimulate alternative approachesAndreas D Meid, Walter E Haefeli
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|January 18, 2018
[Electronic decision support to promote medication safety]Walter E Haefeli, Hanna M Seidling
Computer Methods and Programs in Biomedicine|December 20, 2005
A similarity measure for case based reasoning modeling with temporal abstraction based on cross-correlationFlorian Hartge, Thomas Wetter, Walter E Haefeli
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 27, 2005
Analysis of methylene blue in human urine by capillary electrophoresisHolger Borwitzky, Walter E Haefeli, Jürgen Burhenne
Clinical Chemistry and Laboratory Medicine|June 13, 2002
Rapid detection of polymorphisms of the nitric oxide cascadeJohanna Weiss, Ruth Fricker, Walter E Haefeli
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 27, 2009
Drug dose adjustments in patients with renal impairmentDavid Czock, Thilo Bertsche, Walter E Haefeli
Clinical Pharmacokinetics|May 1, 2015
Use of microdose phenotyping to individualise dosing of patientsNicolas Hohmann, Walter E Haefeli, Gerd Mikus
Expert Opinion on Drug Metabolism & Toxicology|March 8, 2016
CYP3A activity: towards dose adaptation to the individualNicolas Hohmann, Walter E Haefeli, Gerd Mikus
European Journal of Clinical Pharmacology|September 10, 2015
Different methods, different results--how do available methods link a patient's anticholinergic load with adverse outcomes?Tanja Mayer, Walter E Haefeli, Hanna M Seidling
Pharmaceutics|September 30, 2020
Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug TransportersJohanna Weiss, Gzona Bajraktari-Sylejmani, Walter E Haefeli
Pageof 36

Showing results (11-20 of 351) with videos related to

Sort By:
Pageof 36
Pharmacoepidemiology and Drug Safety|September 16, 2017
Refining estimates of prescription durations by using observed covariates in pharmacoepidemiologic databases: Necessary refinements to stimulate alternative approachesAndreas D Meid, Walter E Haefeli
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|January 18, 2018
[Electronic decision support to promote medication safety]Walter E Haefeli, Hanna M Seidling
Computer Methods and Programs in Biomedicine|December 20, 2005
A similarity measure for case based reasoning modeling with temporal abstraction based on cross-correlationFlorian Hartge, Thomas Wetter, Walter E Haefeli
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 27, 2005
Analysis of methylene blue in human urine by capillary electrophoresisHolger Borwitzky, Walter E Haefeli, Jürgen Burhenne
Clinical Chemistry and Laboratory Medicine|June 13, 2002
Rapid detection of polymorphisms of the nitric oxide cascadeJohanna Weiss, Ruth Fricker, Walter E Haefeli
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 27, 2009
Drug dose adjustments in patients with renal impairmentDavid Czock, Thilo Bertsche, Walter E Haefeli
Clinical Pharmacokinetics|May 1, 2015
Use of microdose phenotyping to individualise dosing of patientsNicolas Hohmann, Walter E Haefeli, Gerd Mikus
Expert Opinion on Drug Metabolism & Toxicology|March 8, 2016
CYP3A activity: towards dose adaptation to the individualNicolas Hohmann, Walter E Haefeli, Gerd Mikus
European Journal of Clinical Pharmacology|September 10, 2015
Different methods, different results--how do available methods link a patient's anticholinergic load with adverse outcomes?Tanja Mayer, Walter E Haefeli, Hanna M Seidling
Pharmaceutics|September 30, 2020
Interaction of Hydroxychloroquine with Pharmacokinetically Important Drug TransportersJohanna Weiss, Gzona Bajraktari-Sylejmani, Walter E Haefeli
Pageof 36